No clinical relevance of cytokeratin positive cells in bone marrow of patients with primary breast cancer

被引：0
|
作者：
Kaul, S. [1 ]
Sonnauer, M. [1 ]
Bartik, B. [1 ]
Zeifang, F. [2 ]
Bastert, G.
Fersis, N. [3 ]
机构：
[1] Univ Frauenklin Heidelberg, Heidelberg, Germany
[2] Orthopad Klin Schlierbach, Heidelberg, Germany
[3] Klinikum Chemnitz, Chemnitz, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2008年 / 68卷
关键词：
disseminated tumor cells; standard immunocytology;
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [21] CYTOKERATIN POSITIVITY IN BONE MARROW CELLS AS PREDICTOR OF ONSET OF BONE METASTASES IN PATIENTS WITH ADVANCED BREAST CANCER
    Loriggiola, Laura
    Lumachi, Franco
    Marino, Filippo
    Chiara, Giordano Bruno
    Basso, Stefano Maria Massimiliano
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S241 - S241
  • [22] The role of Cytokeratin- and EpCAM-positive cells in bone marrow of prostate cancer patients
    Polzer, Bernhard
    Weckermann, Dorothea
    Blana, Andreas
    Appel, Inka
    Lottaz, Claudio
    Klein, Christoph
    CANCER RESEARCH, 2009, 69
  • [23] The prognostic impact of cytokeratin-positive cells in bone marrow of patients with localized prostate cancer
    Lilleby, W
    Nesland, JN
    Fossa, SD
    Torlakovic, G
    Waehre, H
    Kvalhem, G
    INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (01) : 91 - 96
  • [24] Immunocytochemical detection of cytokeratin positive cells in human bone marrow of gastric and colorectal cancer patients
    Leinung, S
    Schonfelder, A
    Schonfelder, M
    ZENTRALBLATT FUR CHIRURGIE, 1998, 123 (05): : 520 - 524
  • [25] Prognostic value of cytokeratin 19 fragment (CYFRA 21-1) and cytokeratin-positive cells in bone marrow samples of breast cancer patients
    Pierga, JY
    Deneux, L
    Bonneton, C
    Vincent-Salomon, A
    Nos, C
    Anract, P
    Magdelénat, H
    Pouillart, P
    Thiery, JP
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2004, 19 (01): : 23 - 31
  • [26] Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer
    Daskalaki, A.
    Agelaki, S.
    Perraki, M.
    Apostolaki, S.
    Xenidis, N.
    Stathopoulos, E.
    Kontopodis, E.
    Hatzidaki, D.
    Mavroudis, D.
    Georgoulias, V.
    BRITISH JOURNAL OF CANCER, 2009, 101 (04) : 589 - 597
  • [27] Detection of cytokeratin-19 mRNA-positive cells in peripheral blood and bone marrow of patients with operable breast cancer
    Daskalaki, A.
    Perraki, M.
    Agelaki, S.
    Apostolaki, S.
    Xenidis, N.
    Stathopoulos, E.
    Hatzidaki, D.
    Mavroudis, D.
    Georgoulias, V.
    EJC SUPPLEMENTS, 2009, 7 (02): : 112 - 112
  • [28] Biologically active cancer cells in the bone marrow of breast cancer patients secrete cytokeratin-19
    Alix-Panabieres, C.
    Vendrell, J.
    Pelle, O.
    Riethdorf, S.
    Mueller, V.
    Fabbro, M.
    Pantel, K.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 12 - 12
  • [29] Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer
    A Daskalaki
    S Agelaki
    M Perraki
    S Apostolaki
    N Xenidis
    E Stathopoulos
    E Kontopodis
    D Hatzidaki
    D Mavroudis
    V Georgoulias
    British Journal of Cancer, 2009, 101 : 589 - 597
  • [30] Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
    Solomayer, EF
    Diel, IJ
    Wallwiener, D
    Bode, S
    Meyberg, G
    Sillem, M
    Gollan, O
    Kramer, MD
    Krainick, U
    Bastert, G
    BRITISH JOURNAL OF CANCER, 1997, 76 (06) : 812 - 818
12345